Content
Frontiers of Medicine >> 2019, Volume 13, Issue 6 doi: 10.1007/s11684-019-0702-z
Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia
. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.. Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100044, China
Abstract
Keywords
acute graft-versus-host disease ; chronic graft-versus-host disease ; National Institutes of Health consensus criteria ; acute myeloid leukemia ; anti-thymocyte globulin
Content